Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Innovent Biologics
284
Innovent Biologics
Industry
Manufacturing
Technology
Biotechnology
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
Suggest edits
Founded
2011
Raised
$831M
Follow us
Companies in the same industry
BioAtla, LLC
Bigfish Bio-tech
Emergent BioSolutions
NuLabel
GrowBLOX Sciences
Algiknit
Cognate Therapeutics
Immatics
ResMed
Ipsen
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$421,000,000
IPO - 2018
$150,000,000
Venture capital (Series E) - 2018
Legend Capital
Rock Springs Capital
Cormorant Asset Management
+6
Team Size
200+
Employees
I work here
Location
China
Headquarters
Explore China
$421,000,000
IPO
AVCJ
Innovent Biologics gains on debut after $421m IPO
PE HUB
China's Innovent prices HK IPO near top end, raises $421 million, say sources: Reuters
PE HUB
China's Innovent Biologics looks to raise up to $422 million in HK IPO, say sources: Reuters
$150,000,000
Venture capital (Series E)
PE HUB
,
ChinaMoneyNetwork
,
AVCJ
CGPM leads $150 mln Series E for Innovent Biologics
Funding
Technology
FinSMEs
Innovent Biologics Completes US$150M Series E Financing
Funding
